Mortality rates among United States veterans with sarcoidosis have been rising since 2004, most notably in men, according to study findings published in Chest. Investigators studied the trends in ...

Among those treated for sarcoidosis in the year following diagnosis, 60% used steroids alone, 13% nonsteroidal immunosuppressives alone, and 27% received both. About 43% of patients with sarcoidosis ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...

Efzofitimod is under clinical development by aTyr Pharma and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

June 11, 2024 — Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic ...

When there is no known risk of lung cancer, healthcare providers can miss subtle signs of this disease. In fact, a third of people who are eventually diagnosed with lung cancer visit their healthcare ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Conclusion JAKi, especially BARI, may be useful and safe in controlling the course of both pulmonary and joint disease in RA-ILD patients, even in refractory cases. References [1]Fernández-Díaz C, et ...

CONCLUSION The airway epithelia seem to be the main target of the inflammatory lesion of the lung in patients with primary Sjögren’s syndrome. It seems to be common, subclinically leading to ...